Effective treatments for everyone with MS

Over the past 20 years there have been vast developments in disease modifying therapies (DMT). There are now around 20 DMTs for MS for people with relapsing remitting MS and some emerging for people with progressive types of MS. But still too many people have nothing to slow or stop their MS getting worse.

We’re continuing to support our world leading clinical trials, and the research programmes that move scientific knowledge from lab to clinic. Including our world-first Octopus trial, to find treatments to slow down, or even stop, disability worsening for people with progressive MS.

Managing the impact of MS

We’re funding research to enable people to holistically manage their MS symptoms, and to improve wellbeing and quality of life. This includes access to a broad range of treatments and therapies and support for self-management.

Driving towards prevention

We’re learning more about what causes MS. Increasing our understanding of who is at risk, so we can identify pathways to prevention.

Putting diversity and inclusion front and centre

We’re ensuring our research reflects the diverse experiences and needs of people with MS. And gives a broader range of people with MS the opportunity to contribute to research.

“I’ve lived with the condition for nearly a decade and I’m a very content individual. I’ve learnt to live with it. But if they could prevent it for others, it would bring a major smile to my face.

“MS doesn’t just affect me, it affects my family as well. So if people didn’t have to go through that struggle, it would be a major change for a lot of families, for a lot of people.

“My main hope is there’ll be a cure for MS one day. I’d like to witness that in my lifetime. In the meantime, I hope that there are new discoveries to slow down or stop the progression, so people can continue to be independent for as long as they can."